Navigation Links
Tibotec Conducts Two Pivotal Phase III Clinical Trials Studying TMC278 in Treatment-Naive Adults with HIV
Date:7/17/2008

- Once-daily TMC278, the third anti-HIV compound to be developed in Tibotec

virology portfolio -

YARDLEY, Pa., July 17 /PRNewswire/ -- Tibotec Pharmaceuticals Ltd. announced today that two major phase III efficacy trials examining TMC278, its investigational non-nucleoside reverse transcriptase inhibitor (NNRTI), in treatment-naive adults with HIV-1, are now recruiting patients. The global trials will compare the efficacy, safety and tolerability of TMC278 (25 mg) once daily oral tablet versus efavirenz (EFV), each coadministered with a background regimen of two nucleoside/nucleotide reverse transcriptase inhibitors (N[t]RTIs), in treatment-naive HIV-1-infected adults.

"Preliminary data have shown TMC278 to be active against HIV for patients who have not previously received treatment," Roger Pomerantz, MD, President of Tibotec Research and Development. "These phase III studies will provide important information on the safety and efficacy of this potential new treatment."

The first phase III, double-blind, randomized study, known as TMC278-C209 or ECHO (Efficacy Comparison in treatment-naive HIV-infected subjects Of TMC278 and EFV), will evaluate TMC278 (25 mg) once daily oral tablet versus EFV (600 mg) once daily, when combined with a fixed background regimen consisting of emtricitabine + tenofovir disoproxil fumarate. A second phase III, double-blind randomized study, known as TMC278-C215 or THRIVE (TMC278 against HIV, in a once daily RegImen Versus Efavirenz), will evaluate TMC278 (25 mg) once daily versus EFV (600 mg) once daily, when combined with an investigator-selected background regimen consisting of two N[t]RTIs (abacavir + lamivudine or tenofovir disoproxil fumarate + emtricitabine or zidovudine + lamivudine).

Each study will be conducted at more than 100 sites in over 20 countries, including the U.S., Canada and several countries in Latin America, among others, and will seek to enroll approximat
'/>"/>

SOURCE Tibotec Pharmaceuticals Ltd.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. AHF Criticizes Tibotec Over Steep Price for Newest AIDS Drug, Etravirine
2. Maine Natural Health Company Conducts Dental Clinical Trial
3. Biodel Inc. Announces the Completion of Its Two Pivotal Trials and the Release of EASD Abstracts Containing Additional Interim Data From Its VIAject(TM) Program
4. Isolagen Completes Pivotal Efficacy Portion of Phase III Studies of Isolagen Therapy(TM) for Wrinkles
5. Terumo Heart Obtains IRB Approval from the University of Michigan to Initiate DuraHeart(TM) Left Ventricular Assist System U.S. Pivotal Trial
6. Pivotal Pulmonary Arterial Hypertension Study Published in The Lancet Concludes That Bosentan (Tracleer(R)) Demonstrates Benefits in Patients With Mildly Symptomatic WHO Functional Class II Disease
7. Victory Pharma, Inc. Reports MGX006 Enters Into Pivotal Development Program
8. European Enrollment Begins in Pivotal Phase 3 Trial of Novel Combination Medicine Developed by Cogentus Pharmaceuticals
9. Medivation Initiates Second Pivotal Phase 3 Trial of Dimebon(TM) in Patients With Alzheimers Disease
10. Nephros Completes Pivotal U.S. Clinical Trial for its Hemodiafiltration Products
11. Auxilium Pharmaceuticals, Inc. Announces XIAFLEX(TM) Meets Primary Endpoint With Statistical Significance (p<0.001) in CORD I Pivotal Phase III Study for Dupuytrens Contracture
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/27/2015)...  Cambrex Corporation (NYSE: CBM, "Cambrex") is pleased to announce ... Financial Officer, will present at the Jefferies 2015 Global Healthcare ... New York City . The ... the Cambrex website at www.cambrex.com in the Investors ... available for 90 days after the live event concludes.  ...
(Date:5/27/2015)... , May 27, 2015  Novartis will ... in 21 medicines and 11 investigational compounds across ... American Society of Clinical Oncology (ASCO) Annual Meeting, ... European Hematology Association (EHA), June 11-14. Data will ... cancer types, including melanoma, lung, breast, kidney and ...
(Date:5/27/2015)... , May 25, 2015 Research and Markets ... of the "Research and Future Development Trend Forecast ... offering. At present, there are 35,600 dialysis ... concentration ratio are large due to the different regional ... dialysis centers in other Asian countries are operated by ...
Breaking Medicine Technology:Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 2Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 3Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 4Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 5Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 6Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 7Novartis presents new data on 21 medicines and 11 investigational compounds at ASCO and EHA 8China Dialysis Market Report: Research and Future Development Trends and Forecasts 2015-2020 2
(Date:5/27/2015)... The Case Management Society of ... provide CMSA's Career and Knowledge Pathways educational program ... strengthen the case/care management workforce by offering aptitude ... mutually beneficial agreement provides Medix, a workforce solutions ... in the healthcare, scientific and IT industries, access ...
(Date:5/27/2015)... CompanionDx announced that its ... analysis in personalized cancer therapy: Non-small cell lung cancer ... of Clinical Oncology (ASCO) as part of their annual ... The molecular and clinical data used for the study ... The study reports improved patient outcomes from a preliminary ...
(Date:5/27/2015)... (PRWEB) May 27, 2015 This ... current state of the Omega-3 industry. The report ... definitions, classifications, applications and industry chain structure. The ... markets including development trends, competitive landscape analysis, and ... Rieber Oils, Camanchaca Fishing Company, Seadragon Marine Oils, ...
(Date:5/27/2015)... “Heroin has never been more plentiful or cheaper, ... from,” says Harford County Sheriff Jeff Gahler, as quoted by ... surging heroin related incidents in Baltimore, police resources are running ... heroin addiction and subsequent abuse before it turns into a ... is a drug and alcohol rehab facility specializing in heroin ...
(Date:5/27/2015)... May 27, 2015 A television program ... MediaSource and Roswell Park Cancer Institute ... The award-winning story, Cancer Can’t Win , highlights ... Park Cancer Institute. The production team followed five people ... months as they received treatment from doctors and medical ...
Breaking Medicine News(10 mins):Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 2Health News:Case Management Society of America Partners with Medix to Offer Career and Knowledge Pathways 3Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 2Health News:CompanionDx® Analyzes Non-small Cell Lung Cancer Data for Personalized Cancer Therapy 3Health News:Omega-3 Market: Global 2015 Analysis & 2020 Forecasts on Market Size 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 2Health News:The Price of Heroin in Baltimore Drops, Surging Use and Causing Rife Overdose Deaths 3Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 2Health News:MediaSource Wins New York Emmy® Award as Premier Health Care Storytellers 3
... sharp increase in the number of fat babies; the trend ... the nation’s obesity epidemic//. ,Researchers from the Harvard ... in the July issue of Obesity, have shown a 73.5% ... have said that infants now are 59% more likely to ...
... were many teenagers in Britain who knew as to how ... shown that several of the teens had admitted that they ... off too early. They explained that teenagers with their lack ... the risks of pregnancies and sexually transmitted infections (STI). ...
... Livingston has accused the NHS of giving false information since ... to remove a non-viable fetus. Doctors at the town's St ... womb was dead. ,After this she underwent a procedure ... weeks she found she was still pregnant. "A scan on ...
... of scars following injection with botulinum toxin (BOTOX?) early ... ,The injection prevents muscle movement from wrinkling the wound ... surface for healing and leaving a smoother final scar.,The ... the early healing phase with the injection improves the ...
... School of Medicine have shown the form of a crucial ... to the DNA .The enzyme, which is named, as a ... novel methods to combat small pox. ,"This enzyme ... biology," says Frederic D. Bushman, PhD, Professor of Microbiology, one ...
... a woman from Hamilton was convicted for not informing her doctors ... son// also being infected. ,She was charged for failing ... for child neglect. She was given a 6-month conditional sentence and ... the sentence on 6ht of April but was reported only yesterday ...
Cached Medicine News:Health News:Study finds Babies In America Getting Fatter 2Health News:Teens In UK Do Not Know How To Use A Condom 2Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 2Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 3Health News:Appearance Of Facial Scars Improved By Botulinum Toxin 4Health News:Penn Researchers Throw Light on the Structure Of Smallpox Virus Protein 2
... First Stop absorbable collagen hemostat. FirstStop is ... handling and removal characteristics. It can easily ... fit the wound. FirstStop products are not ... peeled away after hemostasis is achieved. As ...
The VasoSeal Low Profile device is designed for smaller sheath angiography procedures. VasoSeal Low Profile. Seal your arterial punctures with confidence....
... D-Stat Flowable Hemostat has a thick, ... application, such as vascular access sites ... is also used as an adjunct ... tissue tracts of femoral access sites ...
The D-Stat Radial hemostat band utilizes a compression band together with the active haemostatic material of the D-Stat to control surface bleeding....
Medicine Products: